Added to YB: 2025-01-15
Pitch date: 2025-01-14
GSK [bullish]
GSK plc
+55.19%
current return
Author Info
No bio for this author
Company Info
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
Market Cap
GBP 72.9B
Pitch Price
GBP 31.45
Price Target
N/A
Dividend
3.36%
EV/EBITDA
8.93
P/E
13.65
EV/Sales
2.70
Sector
Pharmaceuticals
Category
value
GSK: A Dollar-Earning Undervalued Gem in Global Pharma
GSK: Long at 1320p. Major USD earner benefiting from strong dollar. Low single-digit P/E, undervalued vs global pharma peers. World-class UK co with poor CEO. Takeover target at £20/share (previous peak). Decades-old valuation when Glaxo was UK's largest by market cap.
Read full article (1 min)